Co-downregulation of cell adhesion proteins α- and β-catenins, p120CTN, e-cadherin, and CD44 in prostatic adenocarcinomas

Human Pathology

Volumn 32, Issue 8, 2001, Pages 849-855

  Kallakury, Bhaskar V S ^a   Sheehan, Christine E ^a   Ross, Jeffrey S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Catenin; CD44; E cadherin; Immunohistochemistry; N cadherin; p120CTN; Prostate

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CELL ADHESION MOLECULE; HERMES ANTIGEN; PROTEIN P120;

ARTICLE; CANCER STAGING; CELL ADHESION; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION;

EID: 0034867746     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.26463     Document Type: Article

References (46)

1. From cadherins to catenins: Cytoplasmic protein interaction and regulation of cell adhesion
2. cas) in bladder tumors
3. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
4. Patterns of α- and β-catenin and E-cadherin expression in colorectal adenomas and carcinomas
5. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
6. Decreased expression of α-catenin is associated with poor prognosis of patients with localized renal cell carcinoma
7. Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharryngeal carcinoma: Close association with advanced disease stage and lymph node metastasis
8. A causal role for E-cadherin in the transition from adenoma to carcinoma
9. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines
10. E-cadherin expression in prostatic carcinoma biopsies: Correlation with tumor grade, DNA content, pathologic stage, and clinical outcome
11. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
12. Relation between aberrant α-catenin expression and loss of E-cadherin function in prostate cancer
13. Aberrant E-cadherin and α-catenin expression in prostate cancer: Correlation with patient survival
14. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma
15. Role of cadherins in the transendothelial migration of melanoma cells in culture
16. Aberrant cadherin expression in bladder carcinoma cells
17. Changes in cadherin-catenin complexes in the progression of human bladder carcinoma
18. Identification of novel cadherins expressed in human melanoma cells
19. Cadherin switching in human prostate cancer progression
20. N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells
21. Complex cadherin expression in human prostate cancer cells
22. Genomic structure of DNA encoding the lymphocyte homing receptor CD 44 reveals at least 12 alternatively spliced exons
23. Decreased levels of CD 44 protein and mRNA in prostate cancer. Correlation with tumor grade and ploidy
24. cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence and prostatic adenocarcinomas
25. E-cadherin and α-catenin expression in human esophageal cancer
26. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer
27. Reduced α-catenin and E-cadherin expression in breast cancer
28. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells
29. α-catenin expression has prognostic value in local and locally advanced prostate cancer
30. β-catenin mutations in human prostate cancer
31. Identification of a new catenin: The tyrosine kinase substrate p120cas associates with E-cadherin complexes
32. Histologic grading of prostate cancer: A perspective
33. The expression of p120ctn protein in breast cancer is independent of α- and β-catenin and E-cadherin
34. Expression of β-catenin in normal breast tissue and breast carcinoma: A comparative study with epithelial cadherin and α-catenin
35. Coordinated changes in expression of cell adhesion molecules in prostate cancer
36. Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology
37. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinical pathologic study of 60 cases
38. E-cadherin and α-, β- and γ-catenin expression in prostate cancers: Correlation with tumour invasion
39. Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: A seven-year follow-up
40. β-catenin expression in human cancers
41. P120-catenin expression in human colorectal cancer
42. Receptor protein tyrosine phosphatase PTPμ associates with cadherins and catenins in vivo
43. cas associates with E-cadherin complexes
44. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
45. CD44 antibody against In (Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T-cells
46. Structural basis of cell-cell adhesion by cadherins